Tags Posts tagged with "$GRNH"

$GRNH

0 2510

Monday (3/14), one of the cannabis industry leaders, GW Pharma (GWPH) announced positive results from its first Phase 3 study of Epidiolex in the treatment of Dravet syndrome. Epidiolex already has orphan drug designation and Fast Track Designation from the FDA for this rare form of epilepsy. Currently there are no treatments approved in the U.S. The Active substance in Epidiolex, cannabidiol or CBD, has been the source of conversation and controversy for years.

Many doctors have even condemned it as a false therapy for things like cancer and, yes, epilepsy. But with the advent of strains like Charlotte’s Web, which have shown to drastically curb the affects of epilepsy, these Phase 3 results may confirm much of what many in the health community has already confirmed, which is that CBD’s can be a strong reactive therapy for debilitating diseases like this.

These findings could mean big things for the marijuana industry, as the ripple effect seems to have already begun. GW Pharma stock sprinted 120% to 84.71 in the stock market Monday, hitting a three-month high above 91, intra-day. The news also jump started other cannabis-related stocks like Insys Therapeutics (INSY), which rose 11% to 18.89, and the recently IPO’d Zynerba Pharmaceuticals (ZYNE), which increased to a six month high of $21.08; up 150%.

Like GW Pharma, Insys is also testing a CBD product in Dravet syndrome, and similarly has been granted an orphan-drug designation from the FDA. Zynerba is developing a form of CBD that can be applied through the skin. In a recent PR, ZYNE reported that in the first half of 2016, the Company expects to report final results from its ongoing Phase 1 single rising dose clinical trial, including results from 12 patients with epilepsy.

Other CBD Related Stocks Seeing More Attention From GW’s Findings:

FBEC Worldwide, Inc. (FBEC)

Originally focused on providing hemp based energy drinks, FBEC has also spread its reach into the quality CBD marketplace through its distribution of Ma Brand CBD. Late last year the company signed a Joint Venture agreement with CBD Globe Distributors Ltd. in which FBEC will own 50.1% of the newly formed Joint Venture LLC and receive 50% of the net profit from its operations. According to CBD Globe, it has invested over $200,000 in production and development of the Ma brand itself and already has 10,000 units packaged and ready for sale. The CBD vaping product has a highly refined CBD oil made from hemp, grown in the United States.

Top UFC contender, Anthony “Rumble” Johnson, has endorsed the company’s hemp energy shot product. Furthermore, its most recent announcements have dealt heavily with revamping its share structure and curbing potential sources of future dilution. FBEC shares rose just over 25% from Monday’s open and closed at the high of day.

GreenGro Technologies, Inc. (GRNH)

GRNH also acquired Greensticks, Inc.; a patent pending technology for an electronic vaporizer for Cannbidiol (CBD). Branded as a new way to medicate, Greensticks is a battery powered electronic vaporizer designed to look like an electronic cigarette. The cartridges are filled with 100% organic liquefied flowers and pharmaceutical grade glycol as found in asthma inhalers.

GRNH recently announced record-breaking 242.94% year-over-year sales growth through the first quarter of 2016. According to the company, this timely growth came as a result of new customers along with renewals and the ongoing expansion of the company’s product lines. Additionally, sales increased by 209.57% from the fourth quarter of 2015 to the first quarter of 2016. Along with many other marijuana stocks, GRNH shares increased by nearly 60% from open to high and closed the Monday session at its HOD of $0.349 on more than 5 times it’s average 30-day volume.

Medical Marijuana Inc. (MJNA)

This marijuana stock saw very heavy volume on Monday with price increasing by a modest 7% from its previous close, Friday. The company announced at the beginning of March that its portfolio investment company, KannaLife Sciences, Inc. has received the necessary 2016 quota allotment from the U.S. DEA to import high-purity, pharmaceutical-grade cannabidiol into the U.S.

KannaLife is currently focused on the feasibility studies with Catalent Pharma to develop a cannabinoid-derived therapeutic agent for the treatment of two neurodegenerative diseases: Hepatic Encephalopathy and Chronic Traumatic Encephalopathy; forms of brain degradation in humans that can be due to things like head trauma.

Cannabis Science, Inc. (CBIS)

This stock saw an incredible day on Monday as well. The stock increased from an opening price of $0.01 to a high of $0.0194. The stock ended the day, closing up just under 50%. The company is continuing testing and providing limited rollouts for its own CBD-based treatment products in California. The company has taken a strong stance to increase shareholder value.

In recent press Cannabis Science’s CEO announced that he will be gifting his own shares to shareholders in lieu of previously announced dividends. That date of record for shareholders has been extended to March 31, 2016.

CV Sciences. (CANV)

The stock saw nearly 3 times its average 30-day volume on Monday fueled by excitement in the marijuana sector. Share prices rallied up more than 75%. In most of the recent press releases, the company has been focused on extinguishing the remainder of its convertible debt and as of early March, CANV management confirmed that 100% of the outstanding convertible promissory notes have been retired.

Following the acquisition of CanX and Canabine earlier this year, the company has taken a firm stance on efforts to develop synthetically-formulated CBD for use in drug development activities. In particular, they are looking to pursue approval of the FDA for drugs with specific indications utilizing cannabidiol as the active pharmaceutical ingredient. Board Chairman James A. McNulty has been an active contributor to biotechnology and health care related companies, including BioDelivery Sciences International, Inc. (BDSI), Hedgepath Pharmaceuticals, Inc. (HPPI), Accentia Biopharmaceuticals, Inc., and Biovest International, Inc. He is also a former shareholder of CanX, which brings this full circle.

Conclusion

There are obviously many more marijuana stocks that could be mentioned here but it would seem that the CBD-centric companies like those mentioned, have begun to benefit from the latest ground breaking announcement that GW Pharma has just made with regard to a successful Phase 3 study. With such a late stage success, we think that the hemp, CBD and cannabis space will be a topic of major discussion in 2016.

 

 

Additional disclosure/disclaimer

An affiliate of MAPH Enterprises, LLC MarijuanaStocks.com | WolfofWeedStreet.com was paid an advertising fee of $60,000 cash & 60 Million Restricted Common shares by FBEC Worldwide Inc. (FBEC) for visual sponsorship of MarijuanaStocks.com | WolfofWeedStreet.com and for visual placement FBEC Worldwide Inc. (FBEC) within written materials. FOR A DURATION OF 5 YEARS BEGINNING JUNE 2015 ending JUNE 2020

0 1158

Greengro Technologies Announces a Grand Opening of Its New Vertical Hydrogarden Superstore on 4.20.2015

ANAHEIM, CA–(Marketwired – Feb 13, 2015) – Greengro Technologies (OTC PINK: GRNH) announced today the grand opening of its newest superstore Vertical Hydrogarden in Orange County, California slated for 4.20.2015 at 1676 W Lincoln Anaheim, Cal 92801.

According to CEO James Haas, “It’s been approximately a year since our acquisition of Vertical Hydrogarden. The existing locations offered us little opportunity for expansion and could no longer support our double digit revenue gains each month. This was a logical decision to develop a better working model for future franchise opportunities nationwide.”

The Hydroponic industry has grown significantly over the past ten years due to increasing medical marijuana use and a health-conscious shift toward organic foods. An increased focus on healthy eating habits will spur demand as more consumers seek out organic pesticide-free produce and opt to grow their own or purchase locally produced organic foods grown using hydroponic grow equipment. In addition, the medical marijuana industry shows no signs of slowing down. Medical marijuana is expected to be approved in an increasing number of US states, which will lead more medical patients and entrepreneurs to buy hydroponic grow equipment to meet the demands of this growing market. Haas added, “To our knowledge, there are 10 additional states with pending legislation to further legalize cannabis. Greengro’s core business is the sale of systems, equipment, and supplies for green agriculture with a large percentage being legal cannabis clients. Market estimates for the overall size of the core market Greengro addresses is in excess of $685 million annually growing at 20%. We believe this new location gives us the footprint model to continue our nationwide expansion and revenue growth.”

The company will make further announcements regarding kickoff marketing events surrounding the Grand Opening of its all New Vertical Hydrogarden Superstore. Featuring products specialists from premier vendors like General Hydroponics.

www.verticalhydrogarden.com https://www.facebook.com/vertical.hydrogarden?fref=ts

About Greengro Technologies
Greengro Technologies (OTC PINK: GRNH) is a world class provider of eco-friendly green technologies with specific domain expertise in indoor and outdoor agricultural science systems serving both the consumer and commercial farming markets. It brings together community and commerce through the growth and distribution of healthy, nutritious foods and vital medicines backed by science and technology. Customers include restaurants, community gardens, and small and large scale commercial clients. Greengro Technologies also provides design, construction and maintenance services to large grow and cultivation operations and collectives in the medical and recreational marijuana sectors.

www.greengrotech.com https://www.facebook.com/GreengroTechnologiesInc?ref=hl

Disclaimer: The Company relies upon the Safe Harbor Laws of 1933, 1934 and 1995 for all public news releases. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessarily estimates reflecting the company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors. Factors which could cause actual results to differ materially from those estimated by the company include, but are not limited to, government regulation; managing and maintaining growth; the effect of adverse publicity; litigation; competition; and other factors which may be identified from time to time in the company’s public announcements.

Contact:
Greengro Technologies, Inc.
CEO James Haas
714-367-6538
Email Contact

0 1285

Greengro Technologies Teams With Veridian Laboratories to Provide Advanced Testing Services for Agriculture and Cannabis

Companies Combined Expertise Will Dramatically Improve Validated Testing

ANAHEIM, CA–(Marketwired – Jan 15, 2015) – Greengro Technologies (OTC: GRNH) announced today that it has entered an agreement with Veridian Laboratories to develop and market advanced testing services and products for the agriculture and cannabis industries.

According to CEO James Haas, “One of the fastest growing areas of agriculture, specifically with cannabis is the demand for consistent validated testing methods. Our goal in teaming with Veridian Labs is to apply supercritical carbon dioxide (CO2) technology with current molecular bio-technology techniques to create a more robust and consistent testing system.”

Veridian Laboratories Inc., based in San Diego, has formed Veridian Analytics LLC to pursue the venture with Greengro. Steve Dizaiy, chief science officer, stated, ” We are pleased to partner with Greengro in the quest to elevate agro botanical technology using our combined skills to bring state of the art equipment and strict control processes to the young emerging cannabis industry.”

Cannabis is a diverse plant with many applications; it contains over 400 unique compounds including cannabinoids, terpenoids, flavinoids, alkaloids and more. Each of these chemical compounds play an important role in the life of the cannabis plant and have unique and varied effects on both potency and purity testing. Availability of information about medical cannabis guarantees the patient can better choose the proper medicine specific to his or her ailments. By identifying the potency and cannabinoid profile with standardized labeling, the doctors and patients are able to measure specific doses and avoid chances for improper dosage.

Dizaiy added, “Today’s testing techniques simply do not provide consistent and validated results from lab to lab. Our services will be conducted in certified and validated facilities utilizing ‘Current Good manufacturing practice’ or ‘cGMP.'”

The companies intend to provide additional details and timelines in the near future.

www.greengrotech.com

About Greengro Technologies
Greengro Technologies (OTC: GRNH) is a world class provider of eco-friendly green technologies with specific domain expertise in indoor and outdoor agricultural science systems serving both the consumer and commercial farming markets. It brings together community and commerce through the growth and distribution of healthy, nutritious foods and vital medicines backed by science and technology. Customers include restaurants, community gardens, small and large scale commercial clients. Greengro Technologies also provides design, construction and maintenance services to large grow and cultivation operations and collectives in the medical and recreational marijuana sectors.

About Veridian Laboratories
Veridian Laboratories Inc. is a biotechnology research and development company with more than 25 years expertise in pharmaceutical drug delivery and is dedicated to improving the quality of life using new delivery technologies for natural products.

Disclaimer: The Company relies upon the Safe Harbor Laws of 1933, 1934 and 1995 for all public news releases. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessarily estimates reflecting the company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors. Factors which could cause actual results to differ materially from those estimated by the company include, but are not limited to, government regulation; managing and maintaining growth; the effect of adverse publicity; litigation; competition; and other factors which may be identified from time to time in the company’s public announcements.

Contact:
Greengro Technologies, Inc.
James Haas
CEO
714-441-1408 Office
714-441-1409 Fax

0 1270

Greengro Technologies Poised for Revenue Growth From BP Gardens/Vertical Hydrogarden Initiatives

ANAHEIM, CA–(Marketwired – Dec 17, 2014) – Greengro Technologies (OTC: GRNH) announced today that it has rounded out its BP Gardens Project Initiative leadership team and achieved its mission to create a local food economy that is adaptable to any locale or environment. Through synergy with Greengro’s subsidiary Vertical Hydrogarden, the company has refined its aquaponics and greenhouse hydroponic systems and is poised to generate revenues from its local efforts and expand the business model to other areas.

CEO James Haas announced the addition of Marisela Nuño, a minority woman owned licensed contractor with vast experience with the private and governmental sector. She will perform business development and join the handpicked team brought together to support identified critical areas; Nancy Caruso, Marine Biologist-aquaponics and education, Kelli Johnson, Chef and Farmer-Operations and Irene Haas-Knight, Retail Management-Quality Control.

To date, Greengro’s BP Gardens team has installed 17 aquaponic systems in area schools and partnered with California State University to provide service learning opportunities for 90 students. The BP Gardens team also manages a 2,000 sq ft community garden project in Long Beach, CA providing opportunities for preschool to college age students to create access to healthy food in the middle of this urban area.

“We set out to have the BP Gardens initiative provide education and community service but soon realized by expanding our mission and the products we sell, we can provide local communities the tools to grow food where they live. Greengro’s retail chain Vertical Hydrogarden stores sell a complete line of advanced gardening products for food production, medicine science, and legal cannabis, making this effort also financially rewarding to our shareholders who invest for revenue growth and profits,” said Haas.

The company, through its diversified business model has also developed a Buena Park, CA farm site and has planted the first of 5 greenhouses which is on target to harvest 3,000 pounds of leafy greens per month. Haas stated, “We have also planted over 5,000 strawberries in 5 varieties utilizing Vertical Hydrogardens vertical towers which we expect to yield 25,000 pounds of fruit by the end of June and will be sold through an ever expanding distribution chain for specialty crops.”

The BP Gardens team is working with investors, civic leaders and non-profit organizations to raise awareness of, and access to Greengro’s cutting edge solutions to many urgent climate and health issues. “We have helped frame the conversation around natural resources and have helped entire communities become good stewards of the environment and through our Vertical Hydrogarden retail stores, provide local communities the tools to grow food where they live,” added Haas.

We expect a busy year at the BP Gardens’ research and development sites. The team is developing an ever expanding distribution chain for the specialty crops it produces. These include restaurants, caterers, farmers markets and non-profit agencies trained in food distribution. As new opportunities arise due to new urban agriculture incentive zones, BP Gardens’ “Controlled Environment Technologies” are shovel ready to build on available space in urban areas. Many cities are eager to promote urban farming as the state of California is beginning to allow cities to develop the thousands of urban lots they acquired when the state’s redevelopment agency was dissolved. We are here to help communities GROW.

The companies websites www.greengrotech.com,www.bpgardens.com andwww.verticalhydrogarden.com offer regular updates including educational videos, projects updates, recipes and nutritional information, and where to find the company’s products.

About Greengro Technologies

Greengro Technologies (OTC: GRNH) is a world class provider of eco-friendly green technologies with specific domain expertise in indoor and outdoor agricultural science systems serving both the consumer and commercial farming markets. It brings together community and commerce through the growth and distribution of healthy, nutritious foods and vital medicines backed by science and technology. Customers include restaurants, community gardens, small and large scale commercial clients. Greengro Technologies also provides design, construction and maintenance services to large grow and cultivation operations and collectives in the medical and recreational marijuana sectors.

Disclaimer: The Company relies upon the Safe Harbor Laws of 1933, 1934 and 1995 for all public news releases. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessarily estimates reflecting the company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors. Factors which could cause actual results to differ materially from those estimated by the company include, but are not limited to, government regulation; managing and maintaining growth; the effect of adverse publicity; litigation; competition; and other factors which may be identified from time to time in the company’s public announcements.

Contact:
Greengro Technologies, Inc.
James Haas
CEO
714-441-1408 Office
714-441-1409 Fax

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
Ad Placements